<p>Sera of HIV-1 patients were tested for binding against different HIV-1 antigens including recombinant gp120<sub>JR-FL</sub>, gp41<sub>JR-FL</sub>, and p24 (A). To check for MPER specific antibodies, serum binding against three different MPER peptides was evaluated (B). To gain better knowledge about the binding epitopes on gp120, sera were tested against the gp120 variable loop truncation variants ΔV1/V2 and ΔV3 (C). Endpoint titers of the patient samples were determined by calculating the highest serum dilution that gives a reading above the blank including three standard deviations.</p
We investigated the relative importance of binding site occupancy and epitope specificity in antibod...
ELISA was used to determine the epitopes of several HIV-1 NAbs by testing binding to SF162 wt Env, S...
2 Epitopes that drive the initial autologous neutralizing antibody response in HIV-1-infected indivi...
<p>ELISA binding of polyclonal plasma antibodies from three most cross-neutralizing plasma (CNP) AII...
In the case-control study of the RV144 vaccine trial, the levels of antibodies to the V1V2 region of...
This article reports the HIV epitope specificity of antibodies present in the sera of HIV-negative p...
Efforts to develop a protective HIV-1 vaccine have been hindered by difficulties in identifying epit...
<p>(A) Antibody affinity constants corresponding to antibody binding to MPER peptide before and afte...
Envelope glycoproteins, gp120 and gp41, of the human immunodeficiency virus type 1 (HIV-1) elicit im...
Antibodies of individuals infected with the human immunodeficiency virus type 1 (HIV-1) were used to...
A specific response of human serum neutralizing antibodies (nAb) to a conformational epitope as a re...
The broadly neutralizing human monoclonal antibodies (MAbs) 2F5 and 4E10, both targeting the highly ...
We have developed two immunoassay systems, one designated HIV (p24, p66, gp41) ELISA that use as ant...
We have analyzed a panel of eight murine monoclonal antibodies (MAbs) that depend on the V2 domain f...
A specific response of human serum neutralizing antibodies (nAb) to a conformational epitope as a re...
We investigated the relative importance of binding site occupancy and epitope specificity in antibod...
ELISA was used to determine the epitopes of several HIV-1 NAbs by testing binding to SF162 wt Env, S...
2 Epitopes that drive the initial autologous neutralizing antibody response in HIV-1-infected indivi...
<p>ELISA binding of polyclonal plasma antibodies from three most cross-neutralizing plasma (CNP) AII...
In the case-control study of the RV144 vaccine trial, the levels of antibodies to the V1V2 region of...
This article reports the HIV epitope specificity of antibodies present in the sera of HIV-negative p...
Efforts to develop a protective HIV-1 vaccine have been hindered by difficulties in identifying epit...
<p>(A) Antibody affinity constants corresponding to antibody binding to MPER peptide before and afte...
Envelope glycoproteins, gp120 and gp41, of the human immunodeficiency virus type 1 (HIV-1) elicit im...
Antibodies of individuals infected with the human immunodeficiency virus type 1 (HIV-1) were used to...
A specific response of human serum neutralizing antibodies (nAb) to a conformational epitope as a re...
The broadly neutralizing human monoclonal antibodies (MAbs) 2F5 and 4E10, both targeting the highly ...
We have developed two immunoassay systems, one designated HIV (p24, p66, gp41) ELISA that use as ant...
We have analyzed a panel of eight murine monoclonal antibodies (MAbs) that depend on the V2 domain f...
A specific response of human serum neutralizing antibodies (nAb) to a conformational epitope as a re...
We investigated the relative importance of binding site occupancy and epitope specificity in antibod...
ELISA was used to determine the epitopes of several HIV-1 NAbs by testing binding to SF162 wt Env, S...
2 Epitopes that drive the initial autologous neutralizing antibody response in HIV-1-infected indivi...